FIELD: chemistry.
SUBSTANCE: invention relates to a compound of formula I , which are used as inhibitors of phosphoinositide 3-kinase (PI3-kinase), having anticancer activity, anti-inflammatory activity or immunoregulatory properties.
EFFECT: technical result is obtaining novel compounds of formula I, as well as pharmaceutical compositions based thereon, which can be used for producing a drug for treating cancer, in particular, cerebral cancer.
23 cl, 1 tbl, 41 ex
Title | Year | Author | Number |
---|---|---|---|
PYRAZOLE DERIVATIVES APPLIED AS PROTEIN KINASE INHIBITORS | 2001 |
|
RU2340611C2 |
SUBSTITUTED 2H-PYRAZOLE DERIVATIVE | 2016 |
|
RU2722363C2 |
ISOINDOLINE COMPOUNDS USED FOR TREATING CANCER | 2009 |
|
RU2527952C2 |
PURINE COMPOUNDS INHIBITING PI3K, AND APPLICATION METHODS | 2009 |
|
RU2509081C2 |
N-7 SUBSTITUTED PURINES AND PYRAZOLOPYRIMIDINES, COMPOSITIONS THEREOF AND METHODS FOR USE | 2010 |
|
RU2515541C2 |
BENZOXEPIN PI3 INHIBITORS AND METHODS FOR USING THEM | 2010 |
|
RU2557658C2 |
BICYCLIC HETEROCYCLIC COMPOUNDS AND THEIR APPLICATIONS | 2020 |
|
RU2811612C2 |
2,6-SUBSTUTED-4-MONOSUBSTITUTED AMINO-PYRIMIDINES AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS | 2005 |
|
RU2417990C2 |
CONDENSED TRICYCLIC BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2689777C1 |
COMBINATIONS OF AKT INHIBITOR COMPOUNDS AND ABIRATERONE, AND APPLICATION METHODS | 2012 |
|
RU2631240C2 |
Authors
Dates
2017-03-03—Published
2013-08-29—Filed